Refine
Year of publication
Document Type
- Article (172)
- Preprint (25)
- Working Paper (2)
- Contribution to a Periodical (1)
- Part of Periodical (1)
Has Fulltext
- yes (201)
Is part of the Bibliography
- no (201)
Keywords
- SARS-CoV-2 (6)
- COVID19-NMR (3)
- Elastic scattering (3)
- Non-structural protein (3)
- Solution NMR-spectroscopy (3)
- inflammation (3)
- Biomarker (2)
- CC16 (2)
- Covid19-NMR (2)
- Deutschland (2)
- Diffraction (2)
- Inflammation (2)
- Lung failure (2)
- Marktanteil (2)
- Polarization (2)
- Protein drugability (2)
- RHIC (2)
- Solution NMR spectroscopy (2)
- Tight junctions (2)
- Uteroglobin (2)
- uteroglobin (2)
- (Hydroxymethyl)diphenyl(piperidinoalkyl)silanes (1)
- 140Ce (1)
- 5'-UTR (1)
- 5_SL4 (1)
- 5′-UTR (1)
- ACLF (1)
- ALK-rearranged NSCLC (1)
- Absatzweg (1)
- Absorption (1)
- Accessibility (1)
- Acute myeloid leukemia (1)
- Age (1)
- Airways (1)
- Ankylosierende Spondylitis (1)
- Ankylosing spondylitis (1)
- Area deprivation (1)
- Axial spondyloarthritis (1)
- Axiale Spondyloarthritis (1)
- B-slope (1)
- BCOR (1)
- BCORL1 (1)
- Benign disorder (1)
- Bioavailability (1)
- Biochemistry (1)
- Biophysics and structural biology (1)
- Bipolar disorder (1)
- Brain (1)
- CAKUT (1)
- CLIF-C ACLF score (1)
- CLIF-C ACLF-R score (1)
- CLP (1)
- COVID-19 (1)
- Caco-2 cells (1)
- Care gaps (1)
- Cell-free synthetic biology (1)
- Charged-particle multiplicity (1)
- Charm quark spatial diffusion coefficient (1)
- Charmonia (1)
- Chronic obstructive airway disease (1)
- Circadian (1)
- Coalescence (1)
- Cognitive impairment (1)
- Cold nuclear matter effects (1)
- Collectivity (1)
- Correlation (1)
- Critical point (1)
- Curcumin micelles (1)
- Curcuminoid concentrations (1)
- Cytokine (1)
- Data sharing (1)
- Density equalizing mapping (1)
- Deuteron production (1)
- Deutsch (1)
- Di-hadron correlations (1)
- Effectivity (1)
- Electromagnetic transitions (1)
- Elliptic flow (1)
- Fachsprache (1)
- Flow (1)
- Fluid overload (1)
- Fonds (1)
- Genetics (1)
- Geschichte 1986-1998 (1)
- Groomed jet radius (1)
- Heavy Ion Experiments (1)
- Heavy Quark Production (1)
- Heavy-Ion Collision (1)
- Heavy-flavor decay electron (1)
- Heavy-ion (1)
- Heavy-ion collisions (1)
- High-income countries (1)
- Higher moments (1)
- Induction chemotherapy (1)
- Intensive care treatment (1)
- Interference fragmentation function (1)
- Investmentfonds (1)
- J/ψ suppression (1)
- Jet substructure (1)
- Kommunikationsmittel (1)
- Langerhans cell histiocytosis (1)
- Lung (1)
- MACS (1)
- MUTARS® RS Cup System (1)
- Macrodomain (1)
- Membrane protein (1)
- Mice (1)
- Mitochondrial dysfunction (1)
- Models & methods for nuclear reactions (1)
- Molecular biology (1)
- Molecular medicine (1)
- Multiple parton interactions (1)
- Muscarinic Antagonists (1)
- Muscarinic Receptors (1)
- NMDA IgA/IgM antibodies (1)
- NMDA antibody (1)
- NMR spectroscopy (1)
- Nanodisc (1)
- Nav channel activity (1)
- Nav1.7 (1)
- Neonatal outcome (1)
- Neutron physics (1)
- Non-covalent mass spectrometry (1)
- Nonflow (1)
- Nuclear reactions (1)
- Nucleic acid-binding domain (1)
- Obstetric care (1)
- Oligomeric State (1)
- PC12 cells (1)
- Parkinson disease (1)
- Pharmacodynamics (1)
- Proteins (1)
- Proton-proton collisions (1)
- Proton–proton collisions (1)
- Psychiatry (1)
- Quality of care (1)
- Quality standards (1)
- Qualitätsstandards (1)
- Quarkonium (1)
- RNA genome (1)
- Radiative capture (1)
- Radiotherapy (1)
- Rare disease (1)
- Research architecture (1)
- Resonance reactions (1)
- Rh(II) catalysis (1)
- SL1 (1)
- SLC20A1 (1)
- SOCS (1)
- STAR (1)
- Seasonal variation (1)
- Shear viscosity (1)
- Sila-difenidol (1)
- Sila-pridinol (1)
- SoftDrop (1)
- Solar insolation (1)
- Spin alignment (1)
- Splitting function (1)
- Sprache der Politik (1)
- Stoppa approach (1)
- Suicide (1)
- Sunlight (1)
- Survival (1)
- TP53 mutation status (1)
- Target validation (1)
- Thermal model (1)
- Tissue distribution (1)
- Tools and resources (1)
- Transepithelial transport (1)
- Transversity (1)
- Tween 80 (1)
- Versorgungslücken (1)
- Versorgungsqualität (1)
- Vitamin D (1)
- Wachstum (1)
- Wahlprogramm (1)
- abnormal returns (1)
- accessory proteins (1)
- acetabular fracture (1)
- acute lung injury (1)
- acute lung injury (ALI) (1)
- acute myeloid leukemia (1)
- acute-on-chronic liver failure (1)
- acute‐on‐chronic liver failure (1)
- aging (1)
- automated patch-clamp (1)
- bladder exstrophy-epispadias complex (1)
- capture (1)
- cell-free protein synthesis (1)
- cerium (1)
- chest injury (1)
- chest trauma (1)
- circulation (1)
- cirrhosis (1)
- cloacal malformation (1)
- cross-section (1)
- density equalizing mapping (1)
- diazo compounds (1)
- directed disulfide bond formation (1)
- distribution channel (1)
- ectopic pregnancy (1)
- ectosomes (1)
- exosomes (1)
- extracellular vesicles (1)
- female health (1)
- functional genetics (1)
- fund growth (1)
- global change (1)
- guidelines (1)
- habitat destruction (1)
- hemodynamic (1)
- infection (1)
- intrinsically disordered region (1)
- investment decisions (1)
- kidney formation (1)
- land use (1)
- loss-of-function (1)
- macrophages (1)
- market shares (1)
- mechanical ventilation (1)
- metallo β lactamases (1)
- microparticles (1)
- microvesicles (1)
- minimal information requirements (1)
- mitochondria (1)
- monocytes (1)
- multiresistant bacteria (1)
- mutual fund performance (1)
- mutual funds (1)
- n_TOF (1)
- neurodegeneration (1)
- neutron (1)
- nonstructural proteins (1)
- nucleosynthesis (1)
- p+p collisions (1)
- pain target (1)
- pathogen (1)
- phagocytes (1)
- politische Sprache (1)
- prevention (1)
- pulmonary failure (1)
- reproducibility (1)
- reproduction biology (1)
- respiratory failure (1)
- rice bran extract (1)
- rigor (1)
- risk stratification (1)
- s-process (1)
- sepsis (1)
- sequential ALK-inhibitor therapy (1)
- spider toxin (1)
- standardization (1)
- structural proteins (1)
- survival (1)
- thiol inhibitors (1)
- tocopherol (1)
- tocotrienol (1)
- trauma (1)
- urinary tract development (1)
- vitamin E (1)
- zebrafish development (1)
Institute
- Physik (111)
- Medizin (34)
- Frankfurt Institute for Advanced Studies (FIAS) (27)
- Biochemie, Chemie und Pharmazie (10)
- Biochemie und Chemie (6)
- Zentrum für Biomolekulare Magnetische Resonanz (BMRZ) (6)
- Biowissenschaften (5)
- Pharmazie (4)
- Center for Financial Studies (CFS) (2)
- Exzellenzcluster Makromolekulare Komplexe (2)
The highly infectious disease COVID-19 caused by the Betacoronavirus SARS-CoV-2 poses a severe threat to humanity and demands the redirection of scientific efforts and criteria to organized research projects. The international COVID19-NMR consortium seeks to provide such new approaches by gathering scientific expertise worldwide. In particular, making available viral proteins and RNAs will pave the way to understanding the SARS-CoV-2 molecular components in detail. The research in COVID19-NMR and the resources provided through the consortium are fully disclosed to accelerate access and exploitation. NMR investigations of the viral molecular components are designated to provide the essential basis for further work, including macromolecular interaction studies and high-throughput drug screening. Here, we present the extensive catalog of a holistic SARS-CoV-2 protein preparation approach based on the consortium’s collective efforts. We provide protocols for the large-scale production of more than 80% of all SARS-CoV-2 proteins or essential parts of them. Several of the proteins were produced in more than one laboratory, demonstrating the high interoperability between NMR groups worldwide. For the majority of proteins, we can produce isotope-labeled samples of HSQC-grade. Together with several NMR chemical shift assignments made publicly available on covid19-nmr.com, we here provide highly valuable resources for the production of SARS-CoV-2 proteins in isotope-labeled form.
Simple Summary: Acute myeloid leukemia (AML) is a genetically heterogeneous disease. Clinical phenotypes of frequent mutations and their impact on patient outcome are well established. However, the role of rare mutations often remains elusive. We retrospectively analyzed 1529 newly diagnosed and intensively treated AML patients for mutations of BCOR and BCORL1. We report a distinct co-mutational pattern that suggests a role in disease progression rather than initiation, especially affecting mechanisms of DNA-methylation. Further, we found loss-of-function mutations of BCOR to be independent markers of poor outcomes in multivariable analysis. Therefore, loss-of-function mutations of BCOR need to be considered for AML management, as they may influence risk stratification and subsequent treatment allocation.
Abstract: Acute myeloid leukemia (AML) is characterized by recurrent genetic events. The BCL6 corepressor (BCOR) and its homolog, the BCL6 corepressor-like 1 (BCORL1), have been reported to be rare but recurrent mutations in AML. Previously, smaller studies have reported conflicting results regarding impacts on outcomes. Here, we retrospectively analyzed a large cohort of 1529 patients with newly diagnosed and intensively treated AML. BCOR and BCORL1 mutations were found in 71 (4.6%) and 53 patients (3.5%), respectively. Frequently co-mutated genes were DNTM3A, TET2 and RUNX1. Mutated BCORL1 and loss-of-function mutations of BCOR were significantly more common in the ELN2017 intermediate-risk group. Patients harboring loss-of-function mutations of BCOR had a significantly reduced median event-free survival (HR = 1.464 (95%-Confidence Interval (CI): 1.005–2.134), p = 0.047), relapse-free survival (HR = 1.904 (95%-CI: 1.163–3.117), p = 0.01), and trend for reduced overall survival (HR = 1.495 (95%-CI: 0.990–2.258), p = 0.056) in multivariable analysis. Our study establishes a novel role for loss-of-function mutations of BCOR regarding risk stratification in AML, which may influence treatment allocation.
The current pandemic situation caused by the Betacoronavirus SARS-CoV-2 (SCoV2) highlights the need for coordinated research to combat COVID-19. A particularly important aspect is the development of medication. In addition to viral proteins, structured RNA elements represent a potent alternative as drug targets. The search for drugs that target RNA requires their high-resolution structural characterization. Using nuclear magnetic resonance (NMR) spectroscopy, a worldwide consortium of NMR researchers aims to characterize potential RNA drug targets of SCoV2. Here, we report the characterization of 15 conserved RNA elements located at the 5′ end, the ribosomal frameshift segment and the 3′-untranslated region (3′-UTR) of the SCoV2 genome, their large-scale production and NMR-based secondary structure determination. The NMR data are corroborated with secondary structure probing by DMS footprinting experiments. The close agreement of NMR secondary structure determination of isolated RNA elements with DMS footprinting and NMR performed on larger RNA regions shows that the secondary structure elements fold independently. The NMR data reported here provide the basis for NMR investigations of RNA function, RNA interactions with viral and host proteins and screening campaigns to identify potential RNA binders for pharmaceutical intervention.
Background Anti-angiogenic treatment is believed to have at least cystostatic effects in highly vascularized tumours like pancreatic cancer. In this study, the treatment effects of the angiogenesis inhibitor Cilengitide and gemcitabine were compared with gemcitabine alone in patients with advanced unresectable pancreatic cancer. Methods A multi-national, open-label, controlled, randomized, parallel-group, phase II pilot study was conducted in 20 centers in 7 countries. Cilengitide was administered at 600 mg/m2 twice weekly for 4 weeks per cycle and gemcitabine at 1000 mg/m2 for 3 weeks followed by a week of rest per cycle. The planned treatment period was 6 four-week cycles. The primary endpoint of the study was overall survival and the secondary endpoints were progression-free survival (PFS), response rate, quality of life (QoL), effects on biological markers of disease (CA 19.9) and angiogenesis (vascular endothelial growth factor and basic fibroblast growth factor), and safety. An ancillary study investigated the pharmacokinetics of both drugs in a subset of patients. Results Eighty-nine patients were randomized. The median overall survival was 6.7 months for Cilengitide and gemcitabine and 7.7 months for gemcitabine alone. The median PFS times were 3.6 months and 3.8 months, respectively. The overall response rates were 17% and 14%, and the tumor growth control rates were 54% and 56%, respectively. Changes in the levels of CA 19.9 went in line with the clinical course of the disease, but no apparent relationships were seen with the biological markers of angiogenesis. QoL and safety evaluations were comparable between treatment groups. Pharmacokinetic studies showed no influence of gemcitabine on the pharmacokinetic parameters of Cilengitide and vice versa. Conclusion There were no clinically important differences observed regarding efficacy, safety and QoL between the groups. The observations lay in the range of other clinical studies in this setting. The combination regimen was well tolerated with no adverse effects on the safety, tolerability and pharmacokinetics of either agent.
A wide variety of enzymatic pathways that produce specialized metabolites in bacteria, fungi and plants are known to be encoded in biosynthetic gene clusters. Information about these clusters, pathways and metabolites is currently dispersed throughout the literature, making it difficult to exploit. To facilitate consistent and systematic deposition and retrieval of data on biosynthetic gene clusters, we propose the Minimum Information about a Biosynthetic Gene cluster (MIBiG) data standard.
An optochemokine tandem was developed to control the release of calcium from endosomes into the cytosol by light and to analyze the internalization kinetics of G-protein coupled receptors (GPCRs) by electrophysiology. A previously constructed rhodopsin tandem was re-engineered to combine the light-gated Ca2+-permeable cation channel Channelrhodopsin-2(L132C), CatCh, with the chemokine receptor CXCR4 in a functional tandem protein tCXCR4/CatCh. The GPCR was used as a shuttle protein to displace CatCh from the plasma membrane into intracellular areas. As shown by patch-clamp measurements and confocal laser scanning microscopy, heterologously expressed tCXCR4/CatCh was internalized via the endocytic SDF1/CXCR4 signaling pathway. The kinetics of internalization could be followed electrophysiologically via the amplitude of the CatCh signal. The light-induced release of Ca2+ by tandem endosomes into the cytosol via CatCh was visualized using the Ca2+-sensitive dyes rhod2 and rhod2-AM showing an increase of intracellular Ca2+ in response to light.
We present the first measurement of fluctuations from event to event in the production of strange particles in collisions of heavy nuclei. The ratio of charged kaons to charged pions is determined for individual central Pb+Pb collisions. After accounting for the fluctuations due to detector resolution and finite number statistics we derive an upper limit on genuine non-statistical fluctuations, perhaps related to a first or second order QCD phase transition. Such fluctuations are shown to be very small.
In this paper we analyze the relation between fund performance and market share. Using three performance measures we first establish that significant differences in the risk-adjusted returns of the funds in the sample exist. Thus, investors may react to past fund performance when making their investment decisions. We estimated a model relating past performance to changes in market share and found that past performance has a significant positive effect on market share. The results of a specification test indicate that investors react to risk-adjusted returns rather than to raw returns. This suggests that investors may be more sophisticated than is often assumed.
Background: 15-20% of all patients initially diagnosed with colorectal cancer develop metastatic disease and surgical resection remains the only potentially curative treatment available. Current 5-year survival following R0-resection of liver metastases is 28-39%, but recurrence eventually occurs in up to 70%. To date, adjuvant chemotherapy has not improved clinical outcomes significantly. The primary objective of the ongoing LICC trial (L-BLP25 In Colorectal Cancer) is to determine whether L-BLP25, an active cancer immunotherapy, extends recurrence-free survival (RFS) time over placebo in colorectal cancer patients following R0/R1 resection of hepatic metastases. L-BLP25 targets MUC1 glycoprotein, which is highly expressed in hepatic metastases from colorectal cancer. In a phase IIB trial, L-BLP25 has shown acceptable tolerability and a trend towards longer survival in patients with stage IIIB locoregional NSCLC.
Methods: This is a multinational, phase II, multicenter, randomized, double-blind, placebo-controlled trial with a sample size of 159 patients from 20 centers in 3 countries. Patients with stage IV colorectal adenocarcinoma limited to liver metastases are included. Following curative-intent complete resection of the primary tumor and of all synchronous/metachronous metastases, eligible patients are randomized 2:1 to receive either L-BLP25 or placebo. Those allocated to L-BLP25 receive a single dose of 300 mg/m2 cyclophosphamide (CP) 3 days before first L-BLP25 dose, then primary treatment with s.c. L-BLP25 930 mug once weekly for 8 weeks, followed by s.c. L-BLP25 930 mug maintenance doses at 6-week (years 1&2) and 12-week (year 3) intervals unless recurrence occurs. In the control arm, CP is replaced by saline solution and L-BLP25 by placebo. Primary endpoint is the comparison of recurrence-free survival (RFS) time between groups. Secondary endpoints are overall survival (OS) time, safety, tolerability, RFS/OS in MUC-1 positive cancers. Exploratory immune response analyses are planned. The primary endpoint will be assessed in Q3 2016. Follow-up will end Q3 2017. Interim analyses are not planned.
Discussion: The design and implementation of such a vaccination study in colorectal cancer is feasible. The study will provide recurrence-free and overall survival rates of groups in an unbiased fashion. Trial Registration EudraCT Number 2011-000218-20
Background: Tobacco is a leading environmental factor in the initiation of respiratory diseases and causes chronic obstructive pulmonary disease (COPD). Suppressor of cytokine signaling (SOCS) family members are involved in the pathogenesis of many inflammatory diseases and SOCS-3 has been shown to play an important role in the regulation, onset and maintenance of airway allergic inflammation indicating that SOCS-3 displays a potential therapeutic target for anti-inflammatory respiratory drugs development. Since chronic obstructive pulmonary disease (COPD) is also characterized by inflammatory changes and airflow limitation, the present study assessed the transcriptional expression of SOCS-3 in COPD.
Methods: Real-time PCR was performed to assess quantitative changes in bronchial biopsies of COPD patients in comparison to unaffected controls.
Results: SOCS-3 was significantly down-regulated in COPD at the transcriptional level while SOCS-4 and SOCS-5 displayed no change.
Conclusions: It can be concluded that the presently observed inhibition of SOCS-3 mRNA expression may be related to the dysbalance of cytokine signaling observed in COPD.
Kann man Wahlaussagen verstehen? : Über die Sprache der Parteiprogramme zur Bundestagswahl 2009
(2009)
Die Sprache der Politik hat nicht den besten Ruf. Als Ergebnis von innerparteilichen Expertenrunden entstehen oft Texte in einer von Bürokratismen durchzogenen Fachsprache. Unverständlich vor allem für die, an die sie gerichtet sind: die Wähler. Wie ist es konkret um die Verständlichkeit der Wahlprogramme 2009 bestellt? Eine Analyse.
Suitable and reproducible experimental models of translational research in reconstructive surgery that allow in-vivo investigation of diverse molecular and cellular mechanisms are still limited. To this end we created a novel murine model of acute hindlimb ischemia-reperfusion to mimic a microsurgical free flap procedure. Thirty-six C57BL6 mice (n = 6/group) were assigned to one control and five experimental groups (subject to 6, 12, 96, 120 hours and 14 days of reperfusion, respectively) following 4 hours of complete hindlimb ischemia. Ischemia and reperfusion were monitored using Laser-Doppler Flowmetry. Hindlimb tissue components (skin and muscle) were investigated using histopathology, quantitative immunohistochemistry and immunofluorescence. Despite massive initial tissue damage induced by ischemia-reperfusion injury, the structure of the skin component was restored after 96 hours. During the same time, muscle cells were replaced by young myotubes. In addition, initial neuromuscular dysfunction, edema and swelling resolved by day 4. After two weeks, no functional or neuromuscular deficits were detectable. Furthermore, upregulation of VEGF and tissue infiltration with CD34-positive stem cells led to new capillary formation, which peaked with significantly higher values after two weeks. These data indicate that our model is suitable to investigate cellular and molecular tissue alterations from ischemia-reperfusion such as occur during free flap procedures.
An accurate measurement of the 140Ce(n,γ) energy-dependent cross-section was performed at the n_TOF facility at CERN. This cross-section is of great importance because it represents a bottleneck for the s-process nucleosynthesis and determines to a large extent the cerium abundance in stars. The measurement was motivated by the significant difference between the cerium abundance measured in globular clusters and the value predicted by theoretical stellar models. This discrepancy can be ascribed to an overestimation of the 140Ce capture cross-section due to a lack of accurate nuclear data. For this measurement, we used a sample of cerium oxide enriched in 140Ce to 99.4%. The experimental apparatus consisted of four deuterated benzene liquid scintillator detectors, which allowed us to overcome the difficulties present in the previous measurements, thanks to their very low neutron sensitivity. The accurate analysis of the p-wave resonances and the calculation of their average parameters are fundamental to improve the evaluation of the 140Ce Maxwellian-averaged cross-section.
Background: Curcuminoids (curcumin, demethoxycurcumin, bis-demethoxycurcumin) are lipophilic polyphenols thought to be effective in the prevention and treatment of neurodegenerative disorders, of which mitochondrial dysfunction is a prominent feature. In particular, older people may thus benefit from increasing their curcuminoid intake. However until now, it is not investigated if there exist age differences in the bioavailability of curcuminoids and therefore, it is unclear if curcumin doses have to be adjusted to age. Thus, we explored if the tissue concentrations and biological activities of curcuminoids are affected by age.
Methods: We investigated age-differences in the bioavailability and tissue distribution of curcuminoids and mitochondrial function in 3- and 18-months old mice fed a control diet or identical diets fortified with 500 or 2000 mg curcuminoids/kg for 3 weeks. Therefore, we measured curcuminoid concentrations in plasma, liver, kidney, and brain, basal and stress-induced levels of adenosine triphosphate (ATP) and mitochondrial membrane potential (MMP) in dissociated brain cells and citrate synthase activity of isolated mitochondria.
Results: Plasma but not liver and kidney curcuminoid concentrations were significantly higher in older mice. Age did not affect ATP concentrations and MMP in dissociated brain cells. After damaging cells with nitrosative stress, dissociated brain cells from old mice had a higher MMP than cells from young animals and were therefore more resistant. Furthermore, this effect was enhanced by curcumin.
Conclusion: Our data suggest that age may affect plasma concentrations, but not the tissue distribution of curcuminoids in mice, but has little impact on mitochondrial function in brain cells.
Introduction: Langerhans Cell Histiocytosis (LCH) represents a rare benign disorder, previously designated as "Histiocytosis X", "Type II Histiocytosis" or "Langerhans Cell Granulomatosis". Clinical presentation includes osteolysis, ulcerations of skin and soft tissues but also involvement of the CNS is described.Because treatment concepts are not well defined the German Cooperative Group on Radiotherapy for Benign Diseases performed a retrospective analysis.
Methods and material: Eight closely cooperating centres collected patients' data of the past 45 years. As study endpoints disease free survival, recurrent disease, death and therapy related side effects were defined.
Results: A total of 80 patients with histologically proven LCH were irradiated within the past 45 years. According to the LCH classification of Greenberger et al. 37 patients had stage Ia, 21 patients stage Ib, 13 patients stage II and 9 patients stage IIIb and the median age was 29 years. The median Follow up was 54 months (range 9-134 months). A total of 39 patients had a surgical intervention and 23 patients a chemotherapy regimen.Radiation treatment was carried out with a median total dose of 15 Gy (range 3-50.4 Gy). The median single fraction was 2 Gy (range 1.8-3 Gy).Overall, 77% patients achieved a complete remission and 12.5% achieved a partial remission. The long-term control rate reached 80%. Within an actuarial overall 5-year survival of 90% no radiogenic side and late effects ≥EORTC/RTOG II° were observed.
Conclusion: In the present study a large collective of irradiated patients was analysed. Radiotherapy (RT) is a very effective and safe treatment option and even low RT doses show sufficient local control.
In 1947, 20 species of Staphylinidae were reported from the Cayman Islands as a result of an Oxford University expedition there in 1938 which made extensive use of a light trap. The list is here expanded to 62 species based on collections by R. R. Askew, G. E. Ball, E. A. Dilbert, B. K. Dozier, E. J. Gerberg, P. J. Fitzgerald, M. C. Thomas, and R. H. Turnbow since 1970, all of whom also used light traps except for a collection or two by flight intercept trap.
Neutron capture on 241Am plays an important role in the nuclear energy production and also provides valuable information for the improvement of nuclear models and the statistical interpretation of the nuclear properties. A new experiment to measure the 241Am(n, γ) cross section in the thermal region and the first few resonances below 10 eV has been carried out at EAR2 of the n_TOF facility at CERN. Three neutron-insensitive C6D6 detectors have been used to measure the neutron-capture gamma cascade as a function of the neutron time of flight, and then deduce the neutron capture yield. Preliminary results will be presented and compared with previously obtained results at the same facility in EAR1. In EAR1 the gamma-ray background at thermal energies was about 90% of the signal while in EAR2 is up to a 25 factor much more favorable signal to noise ratio. We also extended the low energy limit down to subthermal energies. This measurement will allow a comparison with neutron capture measurements conducted at reactors and using a different experimental technique.